IOL Chemicals and Pharmaceuticals Limited's Board of Directors in its meeting held on February 6, 2019, approved appointment of Mr. Rajender Mohan Malla as Additional and Independent Director for a period of three years with effect from 6 February 2019 subject to the approval of the shareholders. The company also approved appointment of Mr. Harpal Singh as Additional and Independent Director for a period of three years with effect from 6 February 2019 subject to the approval of the shareholders. The company also approved reconstitution of Audit and Risk Management Committee includes: Mr. Harpal Singh, Independent Director (Chairman); Mr. Chandra Mohan, Independent Director; Dr. Sandhya Mehta, Independent Director; and Mr. Vijay Garg, Joint Managing Director. Nomination and Remuneration Committee includes: Mr. Chandra Mohan, Independent Director (Chairman); Mr. Rajender Mohan Malla, Independent Director; and Dr. Sandhya Mehta, Independent Director. Stakeholders Relationship Committee; Dr. Sandhya Mehta, Independent Director (Chairman); Mr. Varinder Gupta, Managing Director; and Mr. Vikas Gupta, Executive Director.